BLOG

360 DX

With Updated FDA Clearance, Digital Pathology Firm PathAI Eyes Expansion

With marketing clearance from the US Food and Drug Administration that reduces the time to validate the use of its software with new hardware, digital pathology firm PathAI said that it plans to expand its reach by giving customers flexibility in the design of their lab systems and future-proofing its technology.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}